Vanlafaxine - Bioavailability studies
R Whyte made this Official Information request to Pharmaceutical Management Agency
This request has an unknown status. We're waiting for R Whyte to read a recent response and update the status.
From: R Whyte
Dear Pharmaceutical Management Agency,
This is a official information request for any and all bioavailability and pharmacodynamic studies that were submitted to or are held by Pharmac for both the current and previous formulations of venlafaxine (Enlax XR, Effexor XR and Arrow Venlafaxine XR).
Yours faithfully,
R Whyte
From: Web Enquiry
Pharmaceutical Management Agency
Dear R Whyte
This email is to acknowledge that your request for information under the
Official Information Act (1982) has been received and is currently being
worked on. We will have a reply to you as soon as possible and no later
than the due date of 17 April 2018.
Kind regards
Dean Zeng
PHARMAC
show quoted sections
From: Web Enquiry
Pharmaceutical Management Agency
Dear R Whyte
Please see attached the response to your OIA request.
Kind regards
Dean Zeng
PHARMAC
show quoted sections
From: Web Enquiry
Pharmaceutical Management Agency
2019 06 release of further information to Mr Whyte.pdf
70K
Download
View as HTML
2019 06 10 Document for release with watermark.pdf
2.0M
Download
View as HTML
Dear Mt Whyte
Please find attached a response to you and the information requested.
Kind regards
Donna Jennings
PHARMAC
show quoted sections
Things to do with this request
- Add an annotation (to help the requester or others)
- Download a zip file of all correspondence
Offensive? Unsuitable?
Requests for personal information and vexatious requests are not considered valid requests for Official Information (read more).
If you believe this request is not suitable, you can report it for attention by the site administrators
Report this requestAct on what you've learnt
Similar requests
Equity of access for low side-effect formulations for therapeutic treatment of anxiety, depression & ADHD
To Ministry of Health by J Bruning
